SciTransfer
Organization

ULMA MEDICAL TECHNOLOGIES SL

Spanish SME developing embedded systems for retinal disease detection and smart manufacturing digitalization across Europe.

Technology SMEdigitalESSMENo active H2020 projects
H2020 projects
5
As coordinator
2
Total EC funding
€1.7M
Unique partners
190
What they do

Their core work

ULMA Medical Technologies is a Spanish SME specializing in embedded systems and intelligent imaging solutions, with a dual focus on medical diagnostics and industrial digitalization. Their flagship work centers on retinal imaging technology for early detection of chronic diseases, which they advanced from feasibility (SME Instrument Phase 1) to full development (Phase 2) with over €1.5M in funding. In parallel, they contribute embedded systems and digital manufacturing expertise to large-scale Industry 4.0 consortia, bridging the gap between hardware-level engineering and smart factory software platforms.

Core expertise

What they specialise in

Retinal imaging for disease preventionprimary
2 projects

Coordinated both RETINAL Phase 1 (2016) and Phase 2 (2018-2022), securing €1.5M total for chronic disease early detection via retinal imaging.

Embedded systems for digital industryprimary
2 projects

Participated in Productive4.0 and Arrowhead Tools, both large-scale digitalization projects focused on electronic components and process automation.

Cyber-physical systems and distributed manufacturingemerging
1 project

Third-party contributor to DiManD (2019-2024), a training network on autonomous manufacturing and manufacturing informatics.

Smart supply chain and factory digitalizationsecondary
1 project

Contributed to Productive4.0 on optimized supply chain management and digital factory simulation.

Evolution & trajectory

How they've shifted over time

Early focus
Digital factory and process automation
Recent focus
Cyber-physical systems and autonomous manufacturing

In their early H2020 period (2016-2018), ULMA focused on digital factory infrastructure — process automation, simulation and modeling, smart production, and electronic components for supply chain optimization. From 2019 onward, their industrial work shifted toward more advanced concepts: distributed manufacturing, cyber-physical systems, autonomous manufacturing, and manufacturing informatics. Throughout both periods, their medical imaging thread (RETINAL) remained constant, suggesting two parallel but distinct business lines.

ULMA is moving from component-level digital factory work toward system-level autonomous manufacturing intelligence, while maintaining a strong medical imaging product line — expect future projects combining embedded AI with both industrial and health applications.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European25 countries collaborated

ULMA operates in two distinct modes: as a project leader for their proprietary medical imaging technology (coordinating both RETINAL phases), and as a specialist contributor in large industrial consortia (Productive4.0 and Arrowhead Tools are 100+ partner projects). With 190 unique partners across 25 countries from just 5 projects, their network is broad but driven primarily by the massive consortia they joined rather than repeated partnerships. They are comfortable both leading small focused projects and embedding in very large multi-national efforts.

Connected to 190 partners across 25 countries, primarily through participation in two very large ECSEL/digital industry consortia (Productive4.0 and Arrowhead Tools). Their network spans most of Europe, with natural ties to Spain's Basque Country industrial ecosystem.

Why partner with them

What sets them apart

ULMA occupies a rare niche: they combine deep embedded systems engineering for industrial digitalization with proprietary medical imaging technology — very few SMEs span both domains. Their Basque Country roots place them in one of Spain's strongest industrial innovation ecosystems (alongside ULMA Group companies). For consortium builders, they bring the ability to develop hardware-software integrated solutions where embedded intelligence meets real-world sensing, whether in a factory or a clinic.

Notable projects

Highlights from their portfolio

  • RETINAL
    Successfully progressed from SME Instrument Phase 1 (€50K feasibility) to Phase 2 (€1.46M development), signaling strong commercial viability of their retinal imaging technology for chronic disease detection.
  • Arrowhead Tools
    Major European digitalization initiative where ULMA contributed to engineering tools for Industry 4.0 solutions, connecting them to a vast network of electronics and automation players.
  • DiManD
    Marie Skłodowska-Curie training network on distributed and autonomous manufacturing — positions ULMA at the frontier of next-generation manufacturing research.
Cross-sector capabilities
Health / medical diagnosticsManufacturing & Industry 4.0Electronic components and systemsAI-powered sensing and imaging
Analysis note: Profile is based on 5 projects with moderate keyword coverage. The RETINAL projects lack topic keywords in the data, so the medical imaging expertise is inferred from project titles and funding scheme (SME Instrument). The dual medical-industrial profile is unusual and well-supported by the data, but deeper technical capabilities within each domain cannot be fully assessed from project metadata alone.